Results 41 to 50 of about 2,976 (190)

Sarcoma immunotherapy. [PDF]

, 2011
Much of our knowledge regarding cancer immunotherapy has been derived from sarcoma models. However, translation of preclinical findings to bedside success has been limited in this disease, though several intriguing clinical studies hint at the potential ...
Gouw, Launce G, Jones, Kevin B, Randall, R Lor, Sharma, Sunil   +3 more
core   +2 more sources

Molecular features evaluation of metastatic foci as the basis for metastatic breast cancer treatment personalization. Is there a place of CDK4/6-inhibitors in late-line therapy after chemotherapeutic regimens?

Медицинский совет, 2021
The problem of metastatic breast cancer treatment is linked with clonal selection both in the process of tumor evolution and under the  influence of  previous treatment.
A. I. Stukan, A. Y. Goryainova, E. V. Lymar, S. V. Sharov, V. V. Antipova   +4 more
doaj   +1 more source

HER2neu over‐expression induces endothelial cell retraction [PDF]

International Journal of Cancer, 2001
Over-expression of the HER2/neu (HER2) proto-oncogene in breast carcinoma imparts an enhanced metastatic potential. Metastasis requires escape of the tumor cell from the vasculature into subjacent tissue, a transmigration event across an endothelial cell (EC) monolayer.
W B, Carter, J B, Hoying, C, Boswell, S K, Williams   +3 more
openaire   +2 more sources

Correlation of primary tumor metabolic parameters with clinical, histopathological and molecular characteristics in breast cancer patients at pre-operative staging FDG-PET/CT study

The Egyptian Journal of Radiology and Nuclear Medicine, 2021
Background The aim of this prospective study was to evaluate the correlation of primary tumor metabolic activity parameters; maximum standardized uptake value (SUVmax) and tumor SUVmax/liver average SUV ratio (TLR) with clinical, histopathological and ...
Asmaa A. AbdElaal, Ahmed M. Zaher, Marwa I. Abdelgawad, Mohamed A. Mekkawy, Lamiaa M. Eloteify   +4 more
doaj   +1 more source

Current perspective - Trastuzumab [PDF]

, 2009
This article will review the available clinical data on the efficacy of trastuzumab in the treatment of both early advanced breast ...
Cameron, D.A., Hall, P.S.
core   +1 more source

Stromal expression of CD10 in breast carcinoma and its correlation with clinicopathological parameters

South Asian Journal of Cancer, 2019
Introduction: Breast cancer is the foremost cause of death in women worldwide with more than one million cases occurring annually. Aim: This study was conducted to study the stromal CD10 expression in breast carcinomas (BCa) and its correlation with ...
Ashish Nitin Dhande, Siddhi Gaurish Sinai Khandeparkar, Avinash R Joshi, Maithili Mandar Kulkarni, Nidhi Pandya, Neelam Mohanapure, Aakriti Aggarwal, Gargi Patil   +7 more
doaj   +1 more source

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma [PDF]

, 2011
Version of ...
Afamefuna Nduaguba, Andrew X Zhu, Aram F Hezel, Cristina Ferrone, Gregory Y Lauwers, Laura E MacConaill, Nabeel Bardeesy, Sarah M Kehoe, Stephanie M Zimmerman, Vikram Deshpande   +9 more
core   +1 more source

7.DEFICIENCY OF SERUM 25-HYDROXYVITAMIN D IN PATIENTS WITH BREAST CANCER IN IRAQ

The Iraqi Journal of Medical Sciences, 2019
Background: Many studies defined the association between vitamin D and breast cancer. The relation between human epidermal growth factor receptor 2 (Her2/nue), estrogen or progesterone receptors and vitamin D in breast cancer patients was not clear ...
Taha H.T. Al-Saigh
doaj   +6 more sources

Expression of GATA3, p63, E-cadherin and Her2Neu Immunohistochemical Stains in Urothelial Carcinoma and their Relationship with Histological Grading and Prognosis- A Cross-sectional Study [PDF]

Journal of Clinical and Diagnostic Research
Introduction: Urinary bladder cancer is the 10th most common cancer worldwide. Cystoscopy and biopsy/Transurethral Resection of Bladder Tumour (TURBT) are the best techniques for diagnosing and staging urinary bladder cancers. Urothelial Carcinomas (UC),
Debarghya Mukherjee, Soumya Dey, Souvik Chatterjee, Madhumita Mondal, Deepali Singh, Mamata Guha Mallick Sinha   +5 more
doaj   +1 more source

Spectral discrimination of breast pathologies in situ using spatial frequency domain imaging [PDF]

, 2013
Introduction: Nationally, 25% to 50% of patients undergoing lumpectomy for local management of breast cancer require a secondary excision because of the persistence of residual tumor.
Barth, Richard J, Cuccia, David J, Krishnaswamy, Venkataramanan, Laughney, Ashley M, Paulsen, Keith D, Pogue, Brian W, Rizzo, Elizabeth J, Schwab, Mary C, Tromberg, Bruce J, Wells, Wendy A   +9 more
core   +5 more sources